Clinical Screening and Diagnosis for Hepatitis C
This page from the Centers for Disease Control and Prevention (CDC) provides comprehensive guidelines on clinical screening and diagnosis for Hepatitis C.
This collection of tools and resources is for providers, staff, and patients who offer or use services to address substance use, and other interested stakeholders. This collection was originally established following an environmental scan on implementing medication-assisted treatment (MAT) for opioid use disorder (OUD) in rural primary care. (See PDFs of Volume 1 (PDF - 609 KB) and Volume 2 (PDF - 1.3 MB) of that scan). Items have been continuously added to this collection since then, and the collection has expanded to cover substance use more broadly, rather than just MAT for OUD.
This page from the Centers for Disease Control and Prevention (CDC) provides comprehensive guidelines on clinical screening and diagnosis for Hepatitis C.
This blog post discusses substance use disorders and their associated stigma. It highlights how improved knowledge about substance use disorders can combat stigma.
The American Medical Association (AMA) offers specialized CME courses in addiction care.
ASAM offers a comprehensive range of CME programs, including live courses, webinars, and on-demand content focused on various aspects of addiction medicine.
This page provides detailed information about Title 42, Part 2 of the Code of Federal Regulations (CFR), which focuses on the confidentiality of substance use disorder patient records.